Skip to main content
. 2010 Sep 10;116(24):5403–5418. doi: 10.1182/blood-2010-06-289272

Table 2.

Clinical GVHD staging strategy

Stage Skin Liver (bilirubin) Gastrointestinal tract Activity (inversely related to GVHD)
0 No GVHD rash < 4-fold increase over baseline No diarrhea Animal unable to respond normally to stimulation
1 Rash < 25% body surface area 4- to 8-fold increase over baseline “Mild” diarrhea with no other cause Severely decreased or altered activity
2 Rash 25%-50% body surface area 8- to 20-fold increase over baseline “Moderate” diarrhea with no other cause Moderately decreased or altered activity
3 Rash > 50% body surface area 20- to 50-fold increase over baseline “Severe” diarrhea with no other cause Normal activity
4 Generalized erythroderma with bullous formation > 50-fold increase over baseline “Very severe” diarrhea with no other cause

GVHD indicates graft-versus-host disease.